HSDT Share Price Performance
US$5.88
-714.12 (-99.18%)
Price US$5.88
Share PriceUS$5.88
HSDT Community Narratives
There are no narratives available yet.
Recent HSDT News & Updates
Helius Medical Technologies, Inc. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -19.76
- Gross Margin
- -89.15%
- Net Profit Margin
- -7,215.25%
- Debt/Equity Ratio
- 0%
Helius Medical Technologies, Inc. Competitors
Snowflake Analysis
About HSDT
- Founded
- n/a
- Employees
- 21
- CEO
- WebsiteView website
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company’s product is Portable Neuromodulation Stimulator, a non- implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.
Market Insight
Why today’s lofty prices test investors, and how to stay invested without losing your edge.
Continue reading
U.S. Market Performance
- 7 Days: 0.5%
- 3 Months: 8.2%
- 1 Year: 20.8%
- Year to Date: 10.6%
Over the last 7 days, the market has remained flat, although notably the Communication Services sector gained 4.7% in that time. More promisingly, the market is up 21% over the past year. Earnings are forecast to grow by 15% annually. Market details ›